Optimizing clinical trial site performance: A focus on three AI capabilities
IBM Business Partners
AUGUST 7, 2023
Additionally, biopharma companies may find themselves building out AI capabilities in-house sporadically and without overarching governance. Therefore, IBM observes that more clients tend to consult AI leaders to help establish governance and enhance AI and data science capabilities, an operating model in the form of co-delivery partnerships.
61 
Let's personalize your content